Adjuvant ado-trastuzumab emtansine improved survival compared with trastuzumab for early HER2-positive breast cancer ... term results of a randomized phase 3 trial. Ado-trastuzumab emtansine ...

Precision medicine is revolutionizing healthcare, and these genomic stocks are leading the way. Therefore, as this sector ...

NEO, originally called AntShares, has been operating since 2014. The NEO price reached its all-time high in 2018 and has ...

Moderna is the only company in its peer group burning cash at an alarming rate. Click here to read more about MRNA stock and ...

We are edging ever closer to the conclusion of the inaugural league phase of the Uefa Champions League and there is plenty to play for on Matchday 7. Catch all the action live on SuperSport.

We conducted a phase 3, multinational, open-label ... and who had a prerandomization culture positive for Mycobacterium tuberculosis. It excluded participants with baseline phenotypic resistance ...

Financial writer recommends Voyager Therapeutics, Inc. for high-risk investors due to promising preclinical Alzheimer's ...

Punjab FC will host Jamshedpur FC in the Indian Super League (ISL) 2024-25 at the Jawaharlal Nehru <a target=_blank href= ...

Detailed price information for Kutcho Copper Corp (KC-X) from The Globe and Mail including charting and trades.

The FDA has greenlighted the drug, datopotamab deruxtecan, for HR-positive, HER2-negative breast ... the broader NSCLC setting. There, the phase 3 AVANZAR trial for Datroway’s investigational ...